FGFR

Carla Tangermann1,2, Avantika Ghosh1,2, Martin Ziegler3,4

  • 1Division of Cancer Research, Department of Thoracic Surgery, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Nature genetics
|December 8, 2025
PubMed
概括

这项研究确定了纤维细胞生长因子受体 (FGFRs) 中可使用药物的突变,这对精确瘤学至关重要. 它提供了FGFR突变的全面目录,这些突变可以激活信号,而不会导致对抑制剂的耐药性,有助于临床决策.